a public good project by the
Synthesis
Company
of California

© 2026

Thomas B. Cooper | doi.page

0 works0 citations0 h-index

Thomas B. Cooper

Publications by Year

Research Areas

Treatment of Major Depression, Schizophrenia research and treatment, Neurotransmitter Receptor Influence on Behavior, Bipolar Disorder and Treatment, Tryptophan and brain disorders

Most-Cited Works

→ The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis(2004)1,018 cited
→ Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia(2000)1,012 cited
→ Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy(2001)682 cited
→ Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction(2005)610 cited
→ Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia(2010)560 cited
→ Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum(2003)558 cited

→ Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder(2002)

537 cited

→ Double-Blind and Placebo-Controlled Study of Lithium for Adolescent Bipolar Disorders With Secondary Substance Dependency(1998)532 cited

→ Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics(2003)466 cited

→ Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder(2002)408 cited